T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
United Airlines
UAL
$41B
| $82.6M | 0.01% |
2,538,061
+159,319
| +7% | +$5.93M |
|
527
Bio-Techne
TECH
$11.2B
| $82.4M | 0.01% |
1,160,260
+154,252
| +15% | +$13.3M |
|
528
Host Hotels & Resorts
HST
$15.6B
| $81.1M | 0.01% |
5,105,893
-28,796,567
| -85% | -$502M |
|
529
Acadia Pharmaceuticals
ACAD
$4.89B
| $80M | 0.01% |
4,891,348
+197,633
| +4% | +$3.2M |
|
|
MRTX
530
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $79.8M | 0.01% |
1,142,755
+91,225
| +9% | +$6.75M |
|
531
Planet Fitness
PLNT
$3.71B
| $79.6M | 0.01% |
1,379,779
-593,857
| -30% | -$42.8M |
|
|
OLPX
532
DELISTED
Olaplex Holdings
OLPX
| $79.4M | 0.01% |
8,314,440
-5,150,561
| -38% | -$73.9M |
|
533
Quanta Services
PWR
$101B
| $78.8M | 0.01% |
618,849
-63,103
| -9% | -$8.63M |
|
534
Unilever
UL
$135B
| $78.2M | 0.01% |
1,451,469
+101,071
| +7% | +$5.28M |
|
535
Warby Parker
WRBY
$3.2B
| $77.8M | 0.01% |
5,833,421
-15,481,503
| -73% | -$206M |
|
536
Lattice Semiconductor
LSCC
$18.2B
| $77.7M | 0.01% |
1,579,486
-10,330,018
| -87% | -$572M |
|
537
CRISPR Therapeutics
CRSP
$5.22B
| $77.6M | 0.01% |
1,187,462
-1,827,089
| -61% | -$132M |
|
|
LSI
538
DELISTED
Life Storage, Inc.
LSI
| $77.4M | 0.01% |
699,207
+62,016
| +10% | +$7.61M |
|
539
Enbridge
ENB
$112B
| $77.4M | 0.01% |
2,087,114
-857,490
| -29% | -$36.2M |
|
540
IQVIA
IQV
$39.8B
| $76.6M | 0.01% |
422,689
+103,213
| +32% | +$22.6M |
|
541
Fair Isaac
FICO
$24B
| $76.5M | 0.01% |
185,722
-484,966
| -72% | -$220M |
|
542
Cactus
WHD
$5.78B
| $76.4M | 0.01% |
1,989,028
-3,370,555
| -63% | -$135M |
|
543
Gold Fields
GFI
$35.4B
| $76.3M | 0.01% |
9,430,217
-179,834
| -2% | -$1.55M |
|
544
Fastenal
FAST
$58.9B
| $76M | 0.01% |
3,302,720
+15,922
| +0.5% | +$401K |
|
|
GTM
545
ZoomInfo Technologies
GTM
$1.25B
| $75.6M | 0.01% |
1,814,807
+1,513,857
| +503% | +$64.3M |
|
546
MarketAxess Holdings
MKTX
$5.72B
| $74.8M | 0.01% |
336,310
-2,644,338
| -89% | -$679M |
|
|
RAPT
547
DELISTED
RAPT Therapeutics
RAPT
| $74.1M | 0.01% |
384,968
-156,867
| -29% | -$29.7M |
|
548
Copart
CPRT
$27.2B
| $73.8M | 0.01% |
2,774,624
-52,144
| -2% | -$1.55M |
|
549
PTC Therapeutics
PTCT
$6.01B
| $73.7M | 0.01% |
1,467,193
-173,793
| -11% | -$8.52M |
|
550
Fox Class B
FOX
$24.4B
| $73.4M | 0.01% |
2,576,096
-1,087,732
| -30% | -$34.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.